Phase 3 Hip Replacement Clinical Trials
4 recruitingPhase 3
What is a Phase 3 trial?
Phase 3 trials compare the new treatment against the current standard of care in large groups, often hundreds to thousands of participants. Successful Phase 3 results are typically required for regulatory approval.
Showing 1–4 of 4 trials
Recruiting
Phase 3
Suzetrigine in Total Hip Arthroplasty
Total Hip Replacement SurgeryPainPain Management+13 more
Hospital for Special Surgery, New York210 enrolled1 locationNCT07226700
Not Yet Recruiting
Phase 2Phase 3
Dexmedetomidine as an adjuvant to levobupivacaine for spinal anaesthesia in elderly patients undergoing hip replacement surgery: Prospective, randomised, double-blinded study.
hip replacement surgery
University Hospital Centre Sestre Milosrdnice60 enrolled1 locationACTRN12623000153617
Completed
Phase 3
REgulation of Coagulation in ORthopedic Surgery to prevent DVT and PE, controlled, double-blind, randomized study of BAY 59-7939 in the extended prevention of VTE in patients undergoing elective total hip replacement.
Patients undergoing total hip replacement.
Bayer Australia Limited2,500 enrolled1 locationACTRN12606000069550
Completed
Phase 3
REgulation of Coagulation in ORthopedic Surgery to prevent DVT and PE, controlled, double-blind, randomized study of BAY 59-7939 in the extended prevention of VTE in patients undergoing elective total hip replacement.
Patients undergoing total hip replacement.
Bayer Australia Limited4,200 enrolled1 locationACTRN12606000068561